#LCSM is an active hashtag on Bluesky. In the last 30 days, 8 people shared 61 posts with it — around 2 a day. Activity is down 37% versus the previous week, peaking on Jul 9 with 6 posts.
www.moffitt.org
Joint Study Aims To Use Simple Blood Test To Detect Lung Cancer
Early detection of lung cancer can lead to higher survival rates and more treatment options
wtop.com
Nonprofit pushing for Medicare coverage of blood test that checks for more than 50 cancers - WTOP News
A blood test that could scan for dozens of cancers at once is being eyed in Congress, as a way to detect cancers earlier and help patients live longer.
www.iaslc.org
Lung Cancer Considered | IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
ascopubs.org
www.nature.com
Matching patients to clinical trials with large language models - Nature Communications
Patient recruitment is challenging for clinical trials. Here, the authors introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models.
wtop.com
Amid funding concerns, promising lung cancer vaccines could be available in next few years - WTOP News
Clinical trials to develop a lung cancer vaccine to treat or prevent the most deadly form of cancer in the U.S. could be available in “the next few years.”
wtop.com
Amid funding concerns, promising lung cancer vaccines could be available in next few years - WTOP News
Clinical trials to develop a lung cancer vaccine to treat or prevent the most deadly form of cancer in the U.S. could be available in “the next few years.”
shorturl.at
Fast Diagnosis, Fragmented Support: Small Cell Lung Cancer Webinar | Lung Cancer Europe — Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
A free Lung Cancer Europe webinar on the gap between progress and reality in small cell lung cancer across Europe. 3 September 2026, 15:00 CEST. Register to join.
www.onclive.com
Emerging Maintenance Strategies May be the Key to Extending Survival in ES-SCLC | OncLive
Millie Das, MD, outlines how maintenance tarlatamab and lurbinectedin may extend survival beyond current 3-year OS rates in ES-SCLC.
www.onclive.com
FDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas | OncLive
The DLL3-targeting antibody-drug conjugate zocilurtatug pelitecan received FDA orphan drug designation for the management of neuroendocrine carcinomas.
www.onclive.com
Rethinking Lung Cancer Screening Paradigms | OncLive
A growing clinical phenomenon of incidentally finding early-stage lung cancer suggests a significant gap in the current screening paradigm.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.